Picture of Morphosys AG logo

MOR Morphosys AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Brief: Morphosys To Present New Phase 3 Manifest-2 Data On Pelabresib In Myelofibrosis

April 24 (Reuters) - MORPHOSYS AG  MORG.DE :
    * MORPHOSYS TO PRESENT NEW PHASE 3 MANIFEST-2 DATA ON
PELABRESIB
IN MYELOFIBROSIS IN ORAL PRESENTATION AT 2024 ASCO ANNUAL
MEETING

Source text for Eikon:  ID:nEQ81FfT1a 
Further company coverage:  MORG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Morphosys AG

See all news